Allison B Chambliss

763 total citations
38 papers, 493 citations indexed

About

Allison B Chambliss is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Allison B Chambliss has authored 38 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Allison B Chambliss's work include Clinical Laboratory Practices and Quality Control (7 papers), Sepsis Diagnosis and Treatment (5 papers) and COVID-19 Clinical Research Studies (4 papers). Allison B Chambliss is often cited by papers focused on Clinical Laboratory Practices and Quality Control (7 papers), Sepsis Diagnosis and Treatment (5 papers) and COVID-19 Clinical Research Studies (4 papers). Allison B Chambliss collaborates with scholars based in United States, Canada and Netherlands. Allison B Chambliss's co-authors include Denis Wirtz, Shyam B. Khatau, Didier Hodzic, Dong‐Hwee Kim, Gregory D. Longmore, Daniel W. Chan, Joshua A. Hayden, Jennifer M. Colby, Mark A. Marzinke and Maitri Shah and has published in prestigious journals such as JAMA, Oncogene and Scientific Reports.

In The Last Decade

Allison B Chambliss

33 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison B Chambliss United States 10 258 157 50 45 41 38 493
Lindsay B. Avery United States 12 243 0.9× 48 0.3× 42 0.8× 16 0.4× 62 1.5× 18 589
Aleksandra Binek United States 12 233 0.9× 45 0.3× 33 0.7× 21 0.5× 19 0.5× 20 483
Joel Paulo Russomano Veiga Brazil 11 220 0.9× 45 0.3× 54 1.1× 28 0.6× 147 3.6× 32 736
Gemma A. Foulds United Kingdom 14 144 0.6× 31 0.2× 38 0.8× 50 1.1× 74 1.8× 28 432
Francesco Guzzi Italy 13 240 0.9× 73 0.5× 29 0.6× 29 0.6× 38 0.9× 18 494
Tomoyuki Ikeda Japan 12 159 0.6× 132 0.8× 39 0.8× 26 0.6× 28 0.7× 34 486
Pengcheng Shi China 12 155 0.6× 42 0.3× 33 0.7× 12 0.3× 59 1.4× 33 329
Emily Gao United States 14 135 0.5× 40 0.3× 56 1.1× 26 0.6× 36 0.9× 25 453
Sandeep Appunni India 13 240 0.9× 105 0.7× 37 0.7× 44 1.0× 94 2.3× 43 534
Valérie Furlan France 17 280 1.1× 83 0.5× 194 3.9× 196 4.4× 136 3.3× 38 1.1k

Countries citing papers authored by Allison B Chambliss

Since Specialization
Citations

This map shows the geographic impact of Allison B Chambliss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison B Chambliss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison B Chambliss more than expected).

Fields of papers citing papers by Allison B Chambliss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison B Chambliss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison B Chambliss. The network helps show where Allison B Chambliss may publish in the future.

Co-authorship network of co-authors of Allison B Chambliss

This figure shows the co-authorship network connecting the top 25 collaborators of Allison B Chambliss. A scholar is included among the top collaborators of Allison B Chambliss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison B Chambliss. Allison B Chambliss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yufei, Pei-Hsun Wu, Allison B Chambliss, Denis Wirtz, & Sean X. Sun. (2025). Unifying fragmented perspectives with additive deep learning for high-dimensional models from partial faceted datasets. PubMed. 2(1). 5–5.
2.
Katzman, Brooke M., et al.. (2024). Promoting Health Equity Through Effective Laboratory Stewardship Strategies. Clinics in Laboratory Medicine. 44(4). 665–677. 1 indexed citations
3.
Wijk, Xander M.R. van, et al.. (2024). Advances in sepsis biomarkers. Advances in clinical chemistry. 117–166. 4 indexed citations
4.
Chambliss, Allison B, Rhona J. Souers, Jonathan R. Genzen, & David M. Manthei. (2024). Reported Awareness and Use of Pyridoxal-5′-Phosphate Supplementation in Alanine Aminotransferase and Aspartate Aminotransferase Assay Reagents: A Survey by the College of American Pathologists Clinical Chemistry Committee. Archives of Pathology & Laboratory Medicine. 149(5). 400–404. 1 indexed citations
5.
Xiao, Yi & Allison B Chambliss. (2023). A Review of Regulations, Terminology, and Practical Approaches to Reportable Range Verification. The Journal of Applied Laboratory Medicine. 8(4). 773–788.
6.
Chambliss, Allison B, Khushbu Patel, Jessica M Colón-Franco, et al.. (2023). AACC Guidance Document on the Clinical Use of Procalcitonin. The Journal of Applied Laboratory Medicine. 8(3). 598–634. 15 indexed citations
7.
Chambliss, Allison B, Xingyao Chen, Carolina Garri, et al.. (2023). Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population. Practical Laboratory Medicine. 36. e00323–e00323. 1 indexed citations
8.
Sharma, Anu, Dina N. Greene, Allison B Chambliss, et al.. (2021). The effect of the Covid-19 shutdown on glycemic testing and control. Clinica Chimica Acta. 519. 148–152. 6 indexed citations
9.
Chambliss, Allison B. (2020). A Yellow-Green Cerebrospinal Fluid Sample. Clinical Chemistry. 66(5). 742–743. 1 indexed citations
10.
11.
Chambliss, Allison B, Susan M. Butler‐Wu, & Jennifer Dien Bard. (2019). Breaking Down Barriers in Laboratory Medicine. The Journal of Applied Laboratory Medicine. 3(4). 735–736.
12.
Chambliss, Allison B, Joshua A. Hayden, & Jennifer M. Colby. (2019). Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clinical Chemistry and Laboratory Medicine (CCLM). 57(9). 1414–1421. 20 indexed citations
13.
Chambliss, Allison B, Susan M. Butler‐Wu, & Jennifer Dien Bard. (2019). Diagnosis and Management of Sepsis and Blood Stream Infections. The Journal of Applied Laboratory Medicine. 3(4). 525–526. 1 indexed citations
14.
Chambliss, Allison B, Teresa L. Parsons, & Mark A. Marzinke. (2017). An Ultraperformance LC-MS/MS Method for the Quantification of the Antimalarial Atovaquone in Plasma. The Journal of Applied Laboratory Medicine. 1(4). 400–409. 5 indexed citations
15.
Shah, Maitri, Eva Martínez-García, Jude M. Phillip, et al.. (2016). MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents. Oncogene. 35(45). 5905–5915. 67 indexed citations
16.
Chambliss, Allison B, et al.. (2016). Rapid screening for targeted genetic variants via high-resolution melting curve analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 55(4). 507–516. 12 indexed citations
17.
Chambliss, Allison B & Daniel W. Chan. (2016). Precision medicine: from pharmacogenomics to pharmacoproteomics. Clinical Proteomics. 13(1). 25–25. 31 indexed citations
18.
Chambliss, Allison B, Anna K. Füzéry, & William Clarke. (2015). Quantification of Hydroxychloroquine in Blood Using Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry (TFLC-MS/MS). Methods in molecular biology. 1383. 177–184. 6 indexed citations
19.
Kim, Dong‐Hwee, Allison B Chambliss, & Denis Wirtz. (2013). The multi-faceted role of the actin cap in cellular mechanosensation and mechanotransduction. Soft Matter. 9(23). 5516–5516. 64 indexed citations
20.
Chambliss, Allison B, et al.. (2013). The LINC-anchored actin cap connects the extracellular milieu to the nucleus for ultrafast mechanotransduction. Scientific Reports. 3(1). 1087–1087. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsay B. Avery Breakdown of academic impact, for papers by Aleksandra Binek Breakdown of academic impact, for papers by Joel Paulo Russomano Veiga Breakdown of academic impact, for papers by Gemma A. Foulds Breakdown of academic impact, for papers by Francesco Guzzi Breakdown of academic impact, for papers by Tomoyuki Ikeda Breakdown of academic impact, for papers by Pengcheng Shi Breakdown of academic impact, for papers by Emily Gao Breakdown of academic impact, for papers by Sandeep Appunni Breakdown of academic impact, for papers by Valérie Furlan
Rankless by CCL
2026